Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs for Schizophrenia
23 tracked Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs in the Schizophrenia race. The class explanation lives on the Dopamine D2 and serotonin 5-HT2A receptors (antagonist) page; the full indication pipeline across every mechanism is on the Schizophrenia page.
19 approved / phase 42 Phase 31 Phase 11 preclinical / unstaged
Head-to-head evidence: Asenapine vs Clozapine · Asenapine vs Iloperidone (Fanapt) · Asenapine vs Loxapine (Adasuve) · Asenapine vs Lurasidone · Asenapine vs Milsaperidone (VHX-896) · Asenapine vs Olanzapine (Zyprexa Relprevv)
The roster
← all Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs